{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:50:39Z","timestamp":1792691439385,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Stroke and Cerebrovascular Diseases"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.jstrokecerebrovasdis.2018.03.016","type":"journal-article","created":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T13:23:44Z","timestamp":1524749024000},"page":"2175-2181","source":"Crossref","is-referenced-by-count":15,"title":["Retrospective Analysis of Argatroban in 353 Patients with Acute Noncardioembolic Stroke"],"prefix":"10.1016","volume":"27","author":[{"given":"Hiroaki","family":"Oguro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Mitaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Takayoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Onoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.016_bib0010","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1055\/s-2007-996131","article-title":"Effect of the thrombin inhibitor argatroban in acute cerebral thrombosis","volume":"23","author":"Kobayashi","year":"1997","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.016_bib0015","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1161\/01.STR.0000131549.20581.ba","article-title":"Argatroban anticoagulation in patients with acute ischemic stroke (ARGIS-1): a randomized, placebo-controlled safety study","volume":"35","author":"LaMonte","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.016_bib0020","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1023\/A:1020426906956","article-title":"Anticoagulant therapy with a selective thrombin inhibitor for acute cerebral infarction: usefulness of coagulation markers for evaluation of efficacy","volume":"13","author":"Urabe","year":"2002","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.016_bib0025","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3995\/jstroke.20.662","article-title":"Effect of the thrombin inhibitor argatroban in acute cerebral thrombosis","volume":"20","author":"Uchimura","year":"1998","journal-title":"Jpn J Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.016_bib0030","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1159\/000351753","article-title":"Comparison of the European and Japanese Guidelines for the Management of Ischemic Stroke","volume":"35","author":"Kern","year":"2013","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.016_bib0035","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.07.044","article-title":"Ozagrel for patients with noncardioembolic ischemic stroke: a propensity score-matched analysis","volume":"25","author":"Wada","year":"2016","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.016_bib0040","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2169\/internalmedicine.41.103","article-title":"Frequency and pathogenesis of silent subcortical brain infarction in acute first-ever ischemic stroke","volume":"41","author":"Adachi","year":"2002","journal-title":"Intern Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.016_bib0045","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2169\/internalmedicine.44.365","article-title":"The present state of acute ischemic stroke therapy in Japan","volume":"44","author":"Okada","year":"2005","journal-title":"Intern Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.016_bib0050","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jstrokecerebrovasdis.2005.09.004","article-title":"Effect of one-shot intravenous 0.42 mega unit urokinase therapy in patients with acute ischemic stroke","volume":"15","author":"Oguro","year":"2004","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.016_bib0055","first-page":"317","article-title":"Clinical evaluation of Japan Stroke Scale compared with NIH Stroke Scale in acute ischemic stroke patients: from Japanese stroke data bank","volume":"34","author":"Kobayashi","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.016_bib0060","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00415-006-0365-y","article-title":"Efficacy of anti-coagulant treatment with argatroban on cardioembolic stroke","volume":"254","author":"Hosomi","year":"2007","journal-title":"J Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.016_bib0065","series-title":"Japanese Guidelines for the Management of Stroke 2015","author":"The Japan Stroke Society","year":"2015"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.016_bib0070","first-page":"887","article-title":"Clinical benefit of an antithrombin agent, MD-805, in acute-phase cerebral thrombosis\u2014a placebo-controlled, multicenter, double-blind, intergroup trial","volume":"161","author":"Tazaki","year":"1992","journal-title":"J Clin Exp Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.016_bib0075","first-page":"273","article-title":"A controlled clinical trial to assess the efficacy and safety of argatroban in treating acute cerebral thrombosis in comparison to sodium ozagrel","volume":"18","author":"Fukuuchi","year":"2001","journal-title":"Neurol Ther"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.016_bib0080","doi-asserted-by":"crossref","first-page":"16","DOI":"10.29245\/2572.942X\/2017\/6.1137","article-title":"Clinical efficacy of ozagrel with or without edaravone in 156 acute stroke patients","volume":"2","author":"Aritake","year":"2017","journal-title":"J Neurol Neuromed"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.016_bib0085","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1161\/STROKEAHA.115.011250","article-title":"Outcomes of argatroban treatment in patients with atherothrombotic stroke: observational nationwide study in Japan","volume":"47","author":"Wada","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.016_bib0090","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.1523\/JNEUROSCI.0369-12.2012","article-title":"Thrombin activity associated with neuronal damage during acute focal ischemia","volume":"32","author":"Chen","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.016_bib0095","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1161\/01.STR.22.10.1276","article-title":"Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons","volume":"22","author":"del Zoppo","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.016_bib0100","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jstrokecerebrovasdis.2010.02.007","article-title":"A combined treatment for acute larger lacunar-type infarction","volume":"20","author":"Yamamoto","year":"2011","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.016_bib0105","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/01.CCM.0000119426.34340.E2","article-title":"Stroke in patients with heparin-induced thrombocytopenia and the effect of argatroban therapy","volume":"32","author":"LaMonte","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.016_bib0110","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000442577","article-title":"Branch atheromatous disease: a clinically meaningful, yet unproven concept","volume":"41","author":"Petrone","year":"2016","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.016_bib0115","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.3892\/mmr.2014.2025","article-title":"Direct thrombin inhibitors: patents 2002-2012 (review)","volume":"9","author":"Kong","year":"2014","journal-title":"Mol Med Rep"},{"issue":"Suppl 1","key":"10.1016\/j.jstrokecerebrovasdis.2018.03.016_bib0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2165\/00000004-000000000-00000","article-title":"Pathology of AtheroThrombosIS (ATIS)","volume":"70","author":"Ueda","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.016_bib0125","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000069318","article-title":"Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters","volume":"15","year":"2003","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.016_bib0130","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/13510002.1996.11747069","article-title":"Antioxidant activity of 3-methyl-1-phenyl-2-pyrazolin-5-one","volume":"2","author":"Yamamoto","year":"1996","journal-title":"Redox Rep"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.016_bib0135","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0168-0102(02)00019-6","article-title":"Combined argatroban and edaravone caused additive neuroprotection against 15\u2009min of forebrain ischemia in gerbils","volume":"43","author":"Jin","year":"2002","journal-title":"Neurosci Res"}],"container-title":["Journal of Stroke and Cerebrovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305718301691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305718301691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T16:10:31Z","timestamp":1530720631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052305718301691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S1052305718301691"],"URL":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2018.03.016","relation":{},"ISSN":["1052-3057"],"issn-type":[{"value":"1052-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}